CVE-2018-10596: CWE-923 in Medtronic 2090 CareLink Programmer
Medtronic 2090 CareLink Programmer uses a virtual private network connection to securely download updates. It does not verify it is still connected to this virtual private network before downloading updates. The affected products initially establish an encapsulated IP-based VPN connection to a Medtronic-hosted update network. Once the VPN is established, it makes a request to a HTTP (non-TLS) server across the VPN for updates, which responds and provides any available updates. The programmer-side (client) service responsible for this HTTP request does not check to ensure it is still connected to the VPN before making the HTTP request. Thus, an attacker could cause the VPN connection to terminate (through various methods and attack points) and intercept the HTTP request, responding with malicious updates via a man-in-the-middle attack. The affected products do not verify the origin or integrity of these updates, as it insufficiently relied on the security of the VPN. An attacker with remote network access to the programmer could influence these communications.
AI Analysis
Technical Summary
CVE-2018-10596 is a high-severity vulnerability affecting all versions of the Medtronic 2090 CareLink Programmer, a medical device programmer used to manage and update implantable cardiac devices. The device uses a VPN connection to securely download software updates from a Medtronic-hosted update network. However, the vulnerability arises because the programmer does not verify that it remains connected to the VPN before requesting updates. Specifically, after establishing an IP-based VPN tunnel, the device makes update requests over HTTP (unencrypted) within the VPN. If the VPN connection is terminated or disrupted, the programmer continues to send HTTP requests outside the VPN, which can be intercepted by an attacker with network access. Since the device does not verify the origin or integrity of the updates and relies solely on the VPN for security, an attacker could perform a man-in-the-middle (MITM) attack by intercepting these HTTP requests and delivering malicious updates. This could lead to unauthorized code execution, compromising the confidentiality, integrity, and availability of the device and potentially endangering patient safety. The vulnerability is classified under CWE-923 (Improper Verification of Cryptographic Signature) because the device fails to verify update authenticity and integrity. Exploitation requires remote network access and some user interaction, but the impact is critical given the medical context. No patches are listed, and no known exploits have been reported in the wild, but the risk remains significant due to the sensitive nature of the device and its update mechanism.
Potential Impact
For European healthcare organizations, this vulnerability poses a serious risk to patient safety and data security. The Medtronic 2090 CareLink Programmer is used to manage implantable cardiac devices, so successful exploitation could lead to malicious firmware or software updates that alter device behavior, potentially causing device malfunction or failure. This could result in severe health consequences for patients, including life-threatening situations. Additionally, compromised devices could leak sensitive patient data, violating GDPR and other data protection regulations, leading to legal and financial repercussions. The disruption of medical device functionality could also undermine trust in healthcare providers and medical device manufacturers. Given the critical nature of healthcare infrastructure in Europe, such vulnerabilities could have cascading effects on hospital operations and emergency response capabilities. The requirement for remote network access means that attackers could exploit this vulnerability from outside the immediate hospital network if proper network segmentation and access controls are not in place.
Mitigation Recommendations
To mitigate this vulnerability, European healthcare providers should implement several specific measures: 1) Network segmentation: Isolate the Medtronic 2090 CareLink Programmer on a dedicated, tightly controlled network segment with strict firewall rules to limit remote network access only to authorized personnel and systems. 2) VPN monitoring and enforcement: Deploy network monitoring tools to detect VPN disconnections or anomalies and configure the programmer or network to block update requests if the VPN is not active. 3) Use of secure update mechanisms: Engage with Medtronic to obtain firmware or software updates that include cryptographic signature verification to ensure update authenticity and integrity. Until such patches are available, consider manual verification processes for updates. 4) Restrict physical and remote access: Limit access to the programmer to trusted users and devices, employing multi-factor authentication and strong access controls. 5) Incident response planning: Develop and test incident response procedures specifically for medical device compromise scenarios. 6) Regular auditing: Conduct frequent security audits and vulnerability assessments on medical device networks to detect potential exploitation attempts. 7) Vendor coordination: Maintain active communication with Medtronic for updates, patches, and security advisories related to the CareLink Programmer.
Affected Countries
Germany, France, United Kingdom, Italy, Spain, Netherlands, Sweden, Belgium, Switzerland, Norway
CVE-2018-10596: CWE-923 in Medtronic 2090 CareLink Programmer
Description
Medtronic 2090 CareLink Programmer uses a virtual private network connection to securely download updates. It does not verify it is still connected to this virtual private network before downloading updates. The affected products initially establish an encapsulated IP-based VPN connection to a Medtronic-hosted update network. Once the VPN is established, it makes a request to a HTTP (non-TLS) server across the VPN for updates, which responds and provides any available updates. The programmer-side (client) service responsible for this HTTP request does not check to ensure it is still connected to the VPN before making the HTTP request. Thus, an attacker could cause the VPN connection to terminate (through various methods and attack points) and intercept the HTTP request, responding with malicious updates via a man-in-the-middle attack. The affected products do not verify the origin or integrity of these updates, as it insufficiently relied on the security of the VPN. An attacker with remote network access to the programmer could influence these communications.
AI-Powered Analysis
Technical Analysis
CVE-2018-10596 is a high-severity vulnerability affecting all versions of the Medtronic 2090 CareLink Programmer, a medical device programmer used to manage and update implantable cardiac devices. The device uses a VPN connection to securely download software updates from a Medtronic-hosted update network. However, the vulnerability arises because the programmer does not verify that it remains connected to the VPN before requesting updates. Specifically, after establishing an IP-based VPN tunnel, the device makes update requests over HTTP (unencrypted) within the VPN. If the VPN connection is terminated or disrupted, the programmer continues to send HTTP requests outside the VPN, which can be intercepted by an attacker with network access. Since the device does not verify the origin or integrity of the updates and relies solely on the VPN for security, an attacker could perform a man-in-the-middle (MITM) attack by intercepting these HTTP requests and delivering malicious updates. This could lead to unauthorized code execution, compromising the confidentiality, integrity, and availability of the device and potentially endangering patient safety. The vulnerability is classified under CWE-923 (Improper Verification of Cryptographic Signature) because the device fails to verify update authenticity and integrity. Exploitation requires remote network access and some user interaction, but the impact is critical given the medical context. No patches are listed, and no known exploits have been reported in the wild, but the risk remains significant due to the sensitive nature of the device and its update mechanism.
Potential Impact
For European healthcare organizations, this vulnerability poses a serious risk to patient safety and data security. The Medtronic 2090 CareLink Programmer is used to manage implantable cardiac devices, so successful exploitation could lead to malicious firmware or software updates that alter device behavior, potentially causing device malfunction or failure. This could result in severe health consequences for patients, including life-threatening situations. Additionally, compromised devices could leak sensitive patient data, violating GDPR and other data protection regulations, leading to legal and financial repercussions. The disruption of medical device functionality could also undermine trust in healthcare providers and medical device manufacturers. Given the critical nature of healthcare infrastructure in Europe, such vulnerabilities could have cascading effects on hospital operations and emergency response capabilities. The requirement for remote network access means that attackers could exploit this vulnerability from outside the immediate hospital network if proper network segmentation and access controls are not in place.
Mitigation Recommendations
To mitigate this vulnerability, European healthcare providers should implement several specific measures: 1) Network segmentation: Isolate the Medtronic 2090 CareLink Programmer on a dedicated, tightly controlled network segment with strict firewall rules to limit remote network access only to authorized personnel and systems. 2) VPN monitoring and enforcement: Deploy network monitoring tools to detect VPN disconnections or anomalies and configure the programmer or network to block update requests if the VPN is not active. 3) Use of secure update mechanisms: Engage with Medtronic to obtain firmware or software updates that include cryptographic signature verification to ensure update authenticity and integrity. Until such patches are available, consider manual verification processes for updates. 4) Restrict physical and remote access: Limit access to the programmer to trusted users and devices, employing multi-factor authentication and strong access controls. 5) Incident response planning: Develop and test incident response procedures specifically for medical device compromise scenarios. 6) Regular auditing: Conduct frequent security audits and vulnerability assessments on medical device networks to detect potential exploitation attempts. 7) Vendor coordination: Maintain active communication with Medtronic for updates, patches, and security advisories related to the CareLink Programmer.
Technical Details
- Data Version
- 5.1
- Assigner Short Name
- icscert
- Date Reserved
- 2018-05-01T00:00:00
- Cisa Enriched
- false
- Cvss Version
- 3.1
- State
- PUBLISHED
Threat ID: 682f64490acd01a2492644db
Added to database: 5/22/2025, 5:52:09 PM
Last enriched: 7/8/2025, 8:58:32 AM
Last updated: 2/6/2026, 1:46:46 PM
Views: 50
Community Reviews
0 reviewsCrowdsource mitigation strategies, share intel context, and vote on the most helpful responses. Sign in to add your voice and help keep defenders ahead.
Want to contribute mitigation steps or threat intel context? Sign in or create an account to join the community discussion.
Related Threats
CVE-2026-1337: CWE-117 Improper Output Neutralization for Logs in neo4j Enterprise Edition
LowCVE-2025-13818: CWE-367 Time-of-check Time-of-use (TOCTOU) Race Condition in ESET spol s.r.o. ESET Management Agent
HighCVE-2026-2055: Information Disclosure in D-Link DIR-605L
MediumCVE-2026-2054: Information Disclosure in D-Link DIR-605L
MediumCVE-2026-2018: SQL Injection in itsourcecode School Management System
MediumActions
Updates to AI analysis require Pro Console access. Upgrade inside Console → Billing.
Need more coverage?
Upgrade to Pro Console in Console -> Billing for AI refresh and higher limits.
For incident response and remediation, OffSeq services can help resolve threats faster.